Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by NOSSENT, J.
Right arrow Articles by SWAAK, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NOSSENT, J.
Right arrow Articles by SWAAK, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 1991; 80: 605-612
© 1991 Association of Physicians

other

Prevalence and Significance of Haematological Abnormalities in Patients with Systemic Lupus Erythematosus

JC NOSSENT and AJG SWAAK

Dr. Daniel den Hoed Kliniek, Department of Rheumatology Rotterdam, The Netherlands

Address for correspondence: Dr JC Nossent, St. Elisabeth Hospital, Willemstad, Curaçao, Netherlands Antilles.

Accepted for publication 16 January 1991.

The occurrence and significance of haematological abnormalities were analysed in 126 prospectively studied patients with systemic lupus erythematosus. Haemolytic anaemia occurred in 13 per cent, neutropenia in 47 per cent, lymphocytopenia in 20 per cent and thrombocytopenia in 27 per cent of all patients. Patients with haemolytic anaemia were less likely to have serositis, but no differences in the incidence of renal or cerebral manifestations were found between the various groups. Infections were mainly associated with the use of corticosteroid therapy. Life-table analysis showed no adverse influence on survival of haemolytic anaemia, neutropenia or lymphocytopenia, but late onset thrombocytopenia was associated with a decreased survival. No relationship was found between thrombocytopenia and the presence of antiphospholipid antibodies or the occurrence of thromboembolic events.

We conclude that late onset thrombocytopenia in patients with systemic lupus erythematosus is associated with a decreased probability of survival but this could not be attributed to thromboembolic events.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann Rheum DisHome page
S Giannouli, M Voulgarelis, P D Ziakas, and A G Tzioufas
Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment
Ann Rheum Dis, February 1, 2006; 65(2): 144 - 148.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
M. Voulgarelis, S. I G Kokori, J. P A Ioannidis, A. G Tzioufas, D. Kyriaki, and H. M Moutsopoulos
Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin
Ann Rheum Dis, March 1, 2000; 59(3): 217 - 222.
[Abstract] [Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.